About Eyenuk
Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company dedicated to preventing blindness and accelerating the transition to predictive and preventative healthcare. The company specializes in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Their mission is to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases.
Their flagship product, the EyeArt® AI Eye Screening System, is designed to make in-clinic, real-time diabetic retinopathy (DR) screening possible for primary care practices, diabetes centers, and optometric offices. The system autonomously analyzes retinal images to detect the presence and extent of lesions, and determines the level of disease based on internationally recognized clinical scales, providing results in under 60 seconds without the need for an eyecare specialist on-site.
Beyond diabetic retinopathy, Eyenuk is developing a portfolio of AI-based products to address other critical eye and systemic diseases. Their innovation pipeline includes solutions for age-related macular degeneration (AMD), glaucoma, stroke risk, cardiovascular risk, and Alzheimer’s disease, leveraging retinal imaging as a window into overall health. The company aims to expand access to crucial screenings, improve patient compliance, and enable early intervention to save sight and potentially impact the management of other chronic conditions.
Focus Areas
Business Intelligence
| Technology | Cloud-based AI platform for autonomous disease detection, risk assessment, and disease surveillance, utilizing deep-learning algorithms and real-time image quality feedback. Integrates with EHR systems and multiple retinal camera models. |
What Physicians Need to Know
Eyenuk's technology, particularly the EyeArt system, empowers physicians and general practitioners to provide comprehensive diabetes care by enabling in-clinic, real-time eye screenings without needing an on-site eye care specialist. This improves patient compliance with annual screenings, reduces unnecessary referrals, and allows ophthalmologists to focus on higher-yield procedures. The system delivers actionable, easy-to-read, ICD-10 compliant reports quickly, enhancing patient education and potentially improving HEDIS measures and CMS 5-Star quality ratings. Its autonomous nature and high accuracy, even with non-dilated images, make it a valuable tool for early detection and prevention of vision loss, addressing the shortage of eye care providers.
Eyenuk's EyeArt system is designed for seamless integration into clinical workflows. It is compatible with multiple fundus cameras from different manufacturers, including Canon CR-2 AF, Canon CR-2 Plus AF, and Topcon NW400, and Optomed Aurora. The system can also integrate with picture archiving and communications/electronic medical records (PACS/EMR) systems. Eyenuk supports federal efforts to promote interoperable standards for ophthalmic imaging data.
Videos
News, demos, and interviews about Eyenuk.
Videos load interactively. If none appear, search YouTube for Eyenuk →
Frequently Asked Questions
Related Companies
VUNO is a leading South Korean medical AI company that develops and commercializes deep learning-based medical AI solutions. The company’s core mission is to leverage AI technology to enhance healthcare by enabling early disease detection and prevention, ultimately aiming to improve the quality of life for patients. VUNO’s solutions analyze a wide range of medical […]
RetiVue is a healthcare AI company specializing in novel widefield retinal camera technology and eye care cloud services. Their mission is to prevent blindness in underserved and medically at-risk populations by providing affordable, high-definition retinal imaging solutions. The company’s flagship product, the EntireEye Imaging System, offers non-contact, non-mydriatic, high-definition image capture with up to a […]
AI Optics is a healthcare AI company dedicated to transforming point-of-care diagnostics through innovative AI-powered retinal screening technology. The company develops portable hardware and AI-based software to bring eye screening out of specialist offices and into primary care and retail health settings, aiming to increase access to eye screening and empower healthcare professionals to make […]
Thirona is a Dutch MedTech company specializing in artificial intelligence (AI) for advanced medical image analysis, primarily focusing on thoracic CT scans, chest X-rays, and retinal images. Founded by scientists Eva van Rikxoort and Bram van Ginneken from the Radboud University Medical Center, Thirona aims to bridge the gap between academic advancements in medical image […]
Google Health, an initiative (formerly a division) of Google, aims to leverage Google’s technology, particularly AI, to improve health outcomes globally. The company focuses on developing AI-powered tools and products to enhance the efficiency of healthcare workflows, reduce administrative burdens, accelerate innovation, and decrease costs. For physicians, this translates to tools like Google Care Studio, […]
Optivate is a healthcare AI company that provides a unified ophthalmology EHR platform designed to streamline workflows, reduce administrative burden, and improve patient care. The platform is purpose-built for ophthalmology and eye care practices, rather than being adapted from generic or multi-specialty systems. It integrates clinical care, practice management, revenue cycle, patient engagement, and optical […]
